Maha Katabi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New York State Common Retirement Fund increased its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 55.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,491 shares of the company’s stock after buying an additional 6,244 shares during the period. New York State Common Retirement Fund’s holdings in Vera […]

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) saw strong trading volume on Thursday . 980,711 shares traded hands during trading, a decline of 21% from the previous session’s volume of 1,245,474 shares.The stock last traded at $43.49 and had previously closed at $41.62. Analysts Set New Price Targets A number of equities analysts have […]

Guggenheim reaffirmed their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $56.00 price target on the stock. Several other brokerages have also commented on VERA. Raymond James raised Vera Therapeutics from an outperform rating to a strong-buy rating and […]

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […]

Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective boosted by Wedbush from $21.00 to $34.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a neutral rating on the stock. A number of other analysts also recently issued reports on the stock. Raymond James raised shares of Vera […]